Maintain accurate batch documentation and follow established contamination control protocols during handling
Janna Goldfeld, PA-C supports patients with medical weight loss care, GLP-1 education, telehealth follow-up, medication guidance, and personalized treatment planning
(MOUNJARO OR ZEPBOUND) is contraindicated in patients with a personal or family history of MTC or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) [see Contraindications (4)]
Otros riesgos incluyen pancreatitis, enfermedad de la vescula biliar, lesin renal aguda por deshidratacin, y con semaglutida, posible empeoramiento de retinopata diabtica
44 Synchronizing sleep with circadian rhythms is especially important for cardiometabolic health